0 01/05/2024 30/04/2025 2025-04-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-05-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP NI611599 2024-05-01 2025-04-30 NI611599 2025-04-30 NI611599 2024-04-30 NI611599 2023-05-01 2024-04-30 NI611599 2024-04-30 NI611599 2023-04-30 NI611599 bus:RegisteredOffice 2024-05-01 2025-04-30 NI611599 bus:LeadAgentIfApplicable 2024-05-01 2025-04-30 NI611599 bus:Director1 2024-05-01 2025-04-30 NI611599 bus:Director2 2024-05-01 2025-04-30 NI611599 bus:Director3 2024-05-01 2025-04-30 NI611599 core:WithinOneYear 2025-04-30 NI611599 core:WithinOneYear 2024-04-30 NI611599 core:RetainedEarningsAccumulatedLosses 2023-05-01 2024-04-30 NI611599 core:RetainedEarningsAccumulatedLosses 2024-05-01 2025-04-30 NI611599 core:ShareCapital 2025-04-30 NI611599 core:ShareCapital 2024-04-30 NI611599 core:RetainedEarningsAccumulatedLosses 2025-04-30 NI611599 core:RetainedEarningsAccumulatedLosses 2024-04-30 NI611599 core:ShareCapital 2023-04-30 NI611599 core:RetainedEarningsAccumulatedLosses 2023-04-30 NI611599 core:PreviouslyStatedAmount core:ShareCapital 2025-04-30 NI611599 core:CostValuation core:Non-currentFinancialInstruments 2025-04-30 NI611599 core:Non-currentFinancialInstruments 2025-04-30 NI611599 core:Non-currentFinancialInstruments 2024-04-30 NI611599 bus:Director1 2024-04-30 NI611599 bus:Director1 2025-04-30 NI611599 bus:Director2 2024-04-30 NI611599 bus:Director2 2025-04-30 NI611599 bus:Director3 2024-04-30 NI611599 bus:Director3 2025-04-30 NI611599 bus:Director1 2023-04-30 NI611599 bus:Director1 2024-04-30 NI611599 bus:Director2 2023-04-30 NI611599 bus:Director2 2024-04-30 NI611599 bus:Director3 2023-04-30 NI611599 bus:Director3 2024-04-30 NI611599 bus:Director1 2023-05-01 2024-04-30 NI611599 bus:Director2 2023-05-01 2024-04-30 NI611599 bus:Director3 2023-05-01 2024-04-30 NI611599 bus:SmallEntities 2024-05-01 2025-04-30 NI611599 bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 NI611599 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 NI611599 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 NI611599 bus:FullAccounts 2024-05-01 2025-04-30
Company registration number: NI611599
Mackey Franchise Ltd
Trading as Mackey (Franchise) Ltd
Unaudited filleted financial statements
30 April 2025
Mackey Franchise Ltd
Contents
Directors and other information
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Mackey Franchise Ltd
Directors and other information
Directors Mr C J Mackey
Mr M J Mackey
Mr R D mackey
Company number NI611599
Registered office 422 - 426 Newtownards Road
Belfast
Antrim
BT4 1HJ
Business address 422 - 426 Newtownards Road
Belfast
Antrim
BT4 1HJ
Accountants James Mc Mahon & Company
35 Castor Bay Road
Lurgan
BT67 9LE
Mackey Franchise Ltd
Statement of financial position
30 April 2025
2025 2024
Note £ £ £ £
Fixed assets
Investments 4 35 35
_______ _______
35 35
Current assets
Debtors 5 1,196,785 595,347
_______ _______
1,196,785 595,347
Creditors: amounts falling due
within one year 6 ( 1,100,285) ( 513,846)
_______ _______
Net current assets 96,500 81,501
_______ _______
Total assets less current liabilities 96,535 81,536
_______ _______
Net assets 96,535 81,536
_______ _______
Capital and reserves
Called up share capital 36 36
Profit and loss account 96,499 81,500
_______ _______
Shareholders funds 96,535 81,536
_______ _______
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 15 December 2025 , and are signed on behalf of the board by:
Mr C J Mackey
Director
Company registration number: NI611599
Mackey Franchise Ltd
Statement of changes in equity
Year ended 30 April 2025
Called up share capital Profit and loss account Total
£ £ £
At 1 May 2023 36 81,500 81,536
Profit for the year 120,000 120,000
_______ _______ _______
Total comprehensive income for the year - 120,000 120,000
Dividends paid and payable ( 120,000) ( 120,000)
_______ _______ _______
Total investments by and distributions to owners - ( 120,000) ( 120,000)
_______ _______ _______
At 30 April 2024 and 1 May 2024 36 81,500 81,536
Profit for the year 119,999 119,999
_______ _______ _______
Total comprehensive income for the year - 119,999 119,999
Dividends paid and payable ( 105,000) ( 105,000)
_______ _______ _______
Total investments by and distributions to owners - ( 105,000) ( 105,000)
_______ _______ _______
At 30 April 2025 36 96,499 96,535
_______ _______ _______
Mackey Franchise Ltd
Notes to the financial statements
Year ended 30 April 2025
1. General information
The company is a private company limited by shares, registered in Norther Ireland. The address of the registered office is Mackey (Franchise) Ltd, 422 - 426 Newtownards Road, Belfast, Antrim, BT4 1HJ.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments
Shares in group undertakings and participating interests Total
£ £
Cost
At 1 May 2024 and 30 April 2025 35 35
_______ _______
Impairment
At 1 May 2024 and 30 April 2025 - -
_______ _______
Carrying amount
At 30 April 2025 35 35
_______ _______
At 30 April 2024 35 35
_______ _______
5. Debtors
2025 2024
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 1,196,785 568,137
Other debtors - 27,210
_______ _______
1,196,785 595,347
_______ _______
6. Creditors: amounts falling due within one year
2025 2024
£ £
Amounts owed to group undertakings and undertakings in which the company has a participating interest 270,057 194,888
Other creditors 830,228 318,958
_______ _______
1,100,285 513,846
_______ _______
7. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2025
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Mr C J Mackey ( 32,391) ( 2,185) ( 34,576)
Mr M J Mackey 27,210 ( 137,366) ( 110,156)
Mr R D mackey ( 63,556) ( 5,215) ( 68,771)
_______ _______ _______
( 68,737) ( 144,766) ( 213,503)
_______ _______ _______
2024
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Mr C J Mackey ( 36,233) 3,842 ( 32,391)
Mr M J Mackey 17,509 9,701 27,210
Mr R D mackey ( 65,227) 1,671 ( 63,556)
_______ _______ _______
( 83,951) 15,214 ( 68,737)
_______ _______ _______